Skip to main content
OpenTrials

Clinical trial condition

Hemophilia B

Explore clinical trials studying Hemophilia B. Study availability and eligibility vary by location and protocol.

205 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia B trial results

Active, not recruiting

A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

NCT05568459

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of Colorado Hemophilia and Thrombosis Center Aurora, Colorado, United States
  • Yale HTC New Haven, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
View all 17 locations
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

NCT03861273

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • UCSF IDS Pharmacy San Francisco, California, United States
  • University of California, San Francisco - Clinical Research Center San Francisco, California, United States
  • University of California, San Francisco - Outpatient Hematology Clinic San Francisco, California, United States
  • The Regents of the University of California, San Francisco campus San Francisco, California, United States
View all 67 locations
View Trial Details
Active, not recruiting

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

NCT05203679

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Nanfang Hospital Southern Medical University Guangzhou, Guangdong, China
  • The Second People's Hospital of Shenzhen Shenzhen, Guangdong, China
View Trial Details
Active, not recruiting

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

NCT01687608

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • University of California at San Diego Medical Center San Diego, California, United States
View all 15 locations
View Trial Details
Active, not recruiting

Observatory of Patients With Haemophilia B Treated by IdElvion®

NCT05086575

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • CHU Amiens - Picardie Amiens, France
  • CH Annecy Genevois Annecy, France
  • CHRU Besançon Besançon, France
  • CHU Bordeaux - Hôpital Pellegrin Bordeaux, France
View all 28 locations
View Trial Details
Completed

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

NCT03938792

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • USF Health Morsani Center For Advanced Healthcare Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • Northwell Health HTC New Hyde Park, New York, United States
  • Washington Institute for Coagulation Seattle, Washington, United States
View all 62 locations
View Trial Details
Completed

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

NCT03307980

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC Davis Ellison Ambulatory Care Clinic Sacramento, California, United States
  • UC Davis Medical Center department of Radiology Sacramento, California, United States
  • UC Davis Medical Center Sacramento, California, United States
View all 25 locations
View Trial Details
Completed

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

NCT06399289

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Beijing Children's Hospital Beijing, Beijing Municipality, China
  • Union Hospital Affiliated to Fujian Medical University Fuzhou, Fujian, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
View Trial Details

Related conditions